BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37518364)

  • 21. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
    Zhang J; Zhou Q; Xie K; Cheng L; Peng S; Xie R; Liu L; Zhang Y; Dong W; Han J; Huang M; Chen Y; Lin T; Huang J; Chen X
    J Exp Clin Cancer Res; 2021 Jun; 40(1):203. PubMed ID: 34154613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
    Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
    Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
    Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z
    Appl Biochem Biotechnol; 2023 Jul; 195(7):4116-4133. PubMed ID: 36656536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer.
    Li Y; Zhou Y; Huang M; Wang Z; Liu D; Liu J; Fu X; Yang S; Shan S; Yang L; Guo Y; Ren P; Chen P; Zeng G; Guo Y; Wang X; DiSanto ME; Zhang X
    Cell Signal; 2023 Feb; 102():110553. PubMed ID: 36473621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-186 suppresses cell proliferation and metastasis in bladder cancer.
    Liang JF; Li PH; Zhu Y; Zheng SS; Liu JW; Song SQ
    Afr Health Sci; 2022 Dec; 22(4):56-63. PubMed ID: 37092087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GREM1 is a potential biomarker for the progression and prognosis of bladder cancer.
    Jiang PC; Xu LZ; Ning JZ; Cheng F
    World J Surg Oncol; 2023 Aug; 21(1):255. PubMed ID: 37605239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ISYNA1 is overexpressed in bladder carcinoma and regulates cell proliferation and apoptosis.
    Guo X; Li HH; Hu J; Duan YX; Ren WG; Guo Q; Liu PH; Cui Y; Liu LF; Chen MF; Chen JB; Zu XB
    Biochem Biophys Res Commun; 2019 Nov; 519(2):246-252. PubMed ID: 31495492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.
    Yang C; Yuan W; Yang X; Li P; Wang J; Han J; Tao J; Li P; Yang H; Lv Q; Zhang W
    Mol Cancer; 2018 Jan; 17(1):19. PubMed ID: 29386015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
    Lu JJ; Su YW; Wang CJ; Li DF; Zhou L
    Tumori; 2019 Jun; 105(3):231-242. PubMed ID: 30674231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
    Chen W; Jiang T; Mao H; Gao R; Zhang H; He Y; Liu C; Chen Q
    Hum Cell; 2020 Jul; 33(3):737-749. PubMed ID: 32207096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-30c-5p arrests bladder cancer G2/M phase and suppresses its progression by targeting PRC1-mediated blocking of CDK1/Cyclin B1 axis.
    Hao Y; Zhu Y; Sun F; Xu D; Wang C
    Cell Signal; 2023 Oct; 110():110836. PubMed ID: 37532136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p.
    Zhang L; Xia HB; Zhao CY; Shi L; Ren XL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):86-96. PubMed ID: 31957821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
    Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
    Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
    J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
    Jiang W; Zhu D; Wang C; Zhu Y
    Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RabGEF1 functions as an oncogene in U251 glioblastoma cells and is involved in regulating AKT and Erk pathways.
    Fan H; Xin T; Dong X; Yang F; Zhang R; Feng S; He D; Guo H; Pang Q
    Exp Mol Pathol; 2021 Feb; 118():104571. PubMed ID: 33166495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Feng F; Chen AP; Wang XL; Wu GL
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.